Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−51.8753 USD
−13.04 M USD
0.00 USD
8.93 M
About GRI Bio, Inc.
Sector
Industry
CEO
W. Marc Hertz
Website
Headquarters
La Jolla
Founded
2009
FIGI
BBG00XZQMLV6
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GRI is 0.7400 USD — it has decreased by −3.90% in the past 24 hours. Watch GRI Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GRI Bio, Inc. stocks are traded under the ticker GRI.
GRI stock has fallen by −17.50% compared to the previous week, the month change is a 5.71% rise, over the last year GRI Bio, Inc. has showed a −97.91% decrease.
We've gathered analysts' opinions on GRI Bio, Inc. future price: according to them, GRI price has a max estimate of 13.00 USD and a min estimate of 10.00 USD. Watch GRI chart and read a more detailed GRI Bio, Inc. stock forecast: see what analysts think of GRI Bio, Inc. and suggest that you do with its stocks.
GRI stock is 6.76% volatile and has beta coefficient of −0.35. Track GRI Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is GRI Bio, Inc. there?
Today GRI Bio, Inc. has the market capitalization of 6.61 M, it has decreased by −19.17% over the last week.
Yes, you can track GRI Bio, Inc. financials in yearly and quarterly reports right on TradingView.
GRI Bio, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
GRI earnings for the last quarter are −0.67 USD per share, whereas the estimation was −0.73 USD resulting in a 8.22% surprise. The estimated earnings for the next quarter are −0.32 USD per share. See more details about GRI Bio, Inc. earnings.
GRI Bio, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
GRI net income for the last quarter is −2.12 M USD, while the quarter before that showed −2.25 M USD of net income which accounts for 5.64% change. Track more GRI Bio, Inc. financial stats to get the full picture.
No, GRI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 4.00 employees. See our rating of the largest employees — is GRI Bio, Inc. on this list?
Like other stocks, GRI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRI Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRI Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRI Bio, Inc. stock shows the sell signal. See more of GRI Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.